婴儿百日咳母亲产前Tdap疫苗接种障碍——加利福尼亚州,2016年
研究访谈了2016年加利福尼亚州婴儿患百日咳的母亲及其产前保健提供者,以查明产前Tdap疫苗接种率低的原因。在常规产前检查时现场提供Tdap疫苗的母亲更可能接种,而被转诊至其他地点接种的母亲接种率较低。 Medicaid参保母亲即使疫苗现场有库存,接种率也低于私人保险母亲;几乎所有接种疫苗的母亲均在产前诊所完成接种。
要点
- 常规产前检查时现场提供Tdap疫苗可提高接种率。
- 被转诊至其他地点接种的母亲接种率较低。
- Medicaid参保母亲接种率低于私人保险母亲,即使疫苗现场有库存。
核心结论
- 将Tdap疫苗接种纳入常规产前保健就诊是提高产前Tdap疫苗接种率的有效手段。
研究设计与样本
- 访谈2016年加利福尼亚州婴儿患百日咳的母亲及其产前保健提供者,以查明产前Tdap疫苗覆盖率低的可能原因。
主要发现
- 在常规产前检查时现场提供Tdap疫苗的母亲比被转诊至其他地点接种的母亲更可能接种疫苗。
- Medicaid参保母亲比私人保险母亲更不可能接种Tdap疫苗,即使疫苗现场有库存。
- 几乎所有接种疫苗的母亲均在产前诊所接种Tdap疫苗。
临床怎么用
- 将Tdap疫苗接种纳入常规产前保健就诊。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended for all pregnant women to protect infants who are too young for vaccination from severe pertussis-related outcomes (1-3). However, Tdap vaccine coverage among pregnant women remains suboptimal in California (4). California mothers whose infants developed pertussis in 2016 and their prenatal care providers were interviewed to ascertain possible reasons for low Tdap vaccine coverage. Mothers who were offered Tdap vaccination on-site during a routine prenatal visit were more likely to be vaccinated than were mothers who were referred off-site for vaccination. Mothers insured by Medicaid were less likely to receive Tdap vaccine than were mothers with private insurance, even when the vaccine was stocked on-site. Nearly all vaccinated mothers received Tdap vaccine in their prenatal clinic. Incorporating Tdap vaccination into routine prenatal care visits is an effective means to increase prenatal Tdap vaccination coverage.
引用
- New S, Winter K, Boyte R, et al. Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis - California, 2016. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30260942. doi:10.15585/mmwr.mm6738a6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。